Preferred Name |
conivaptan |
|
Synonyms |
YM087 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C106389 |
|
altLabel |
YM087 CI-1025 conivaptan hydrochloride conivaptan HCl YM-087 (1,1'-biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)- YM 087 Vaprisol (1,1'-biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-, monohydrochloride 4''-((4,5-dihydro-2-methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide |
|
cui |
C1700196 C1698656 C0966107 C5773963 C0539859 |
|
HM |
D001552 |
|
Inverse of RB |
75L57R6X36 0NJ98Y462X 0 |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
19970630 |
|
MeSH Frequency |
175 |
|
MMR |
20220908 |
|
notation |
C106389 |
|
PA |
D065092 |
|
prefLabel |
conivaptan |
|
RR |
75L57R6X36 |
|
SC |
1 |
|
SRC |
Eur J Pharmacol 1997 Feb 26;321(2):225-30 |
|
TERMUI |
T000911167 T000911166 T446729 T673906 T758842 T307246 T307245 T001124581 T001124580 T000911170 T001124579 |
|
TH |
NLM (1997) INN (2009) FDA SRS (2013) FDA SRS (2017) NLM (2001) NLM (2022) USAN (19XX) INN (19XX) NLM (2006) NLM (2017) |
|
tui |
T109 T121 |